Price Target Changed • May 20
Price target increased by 238% to €25.00 Up from €7.40, the current price target is provided by 1 analyst. New target price is 60% above last closing price of €15.65. Stock is up 123% over the past year. The company is forecast to post a net loss per share of €0.44 compared to earnings per share of €0.0012 last year. Duyuru • Jun 24
IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025 IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025 Duyuru • Apr 17
IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025 IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time. Duyuru • Apr 16
Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025 Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures. Duyuru • Jan 08
IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025 IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025 Price Target Changed • Dec 30
Price target decreased by 38% to €7.40 Down from €12.00, the current price target is provided by 1 analyst. New target price is 13% above last closing price of €6.52. Stock is down 64% over the past year. The company posted a net loss per share of €0.52 last year. Reported Earnings • Sep 01
First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023) First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance. Duyuru • Aug 29
IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024 IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024 Duyuru • Mar 22
IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024 IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024. Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to €11.46, the stock trades at a trailing P/E ratio of 51.8x. Average forward P/E is 18x in the Chemicals industry in Germany. Total loss to shareholders of 74% over the past three years. Duyuru • Mar 21
IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024 IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024 New Risk • Mar 12
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m). Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €15.98, the stock trades at a trailing P/E ratio of 65.2x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 56% over the past three years. Valuation Update With 7 Day Price Move • Jan 13
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to €13.68, the stock trades at a trailing P/E ratio of 56.9x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 44% over the past three years. New Risk • Dec 09
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m). Valuation Update With 7 Day Price Move • Oct 20
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to €18.00, the stock trades at a forward P/E ratio of 62x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 42% over the past three years. Reported Earnings • Aug 30
First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022) First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Aug 28
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change). Upcoming Dividend • Apr 20
Upcoming dividend of €0.04 per share at 0.1% yield Eligible shareholders must have bought the stock before 27 April 2023. Payment date: 02 May 2023. Trailing yield: 0.1%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.3%). Reported Earnings • Mar 27
Full year 2022 earnings released Full year 2022 results: Revenue: €56.0m (up 26% from FY 2021). Net income: €1.28m (up €1.52m from FY 2021). Profit margin: 2.3% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany. Price Target Changed • Nov 16
Price target decreased to €58.00 Down from €64.50, the current price target is provided by 1 analyst. New target price is 119% above last closing price of €26.50. Stock is down 38% over the past year. The company is forecast to post earnings per share of €0.13 next year compared to a net loss per share of €0.049 last year. Valuation Update With 7 Day Price Move • Oct 08
Investor sentiment improved over the past week After last week's 20% share price gain to €19.06, the stock trades at a forward P/E ratio of 58x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 14% over the past three years. Valuation Update With 7 Day Price Move • Sep 17
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €17.56, the stock trades at a forward P/E ratio of 54x. Average forward P/E is 9x in the Chemicals industry in Germany. Total returns to shareholders of 5.0% over the past three years. Reported Earnings • Sep 02
First half 2022 earnings released: EPS: €0 (vs €0.23 loss in 1H 2021) First half 2022 results: EPS: €0 (up from €0.23 loss in 1H 2021). Revenue: €30.7m (up 53% from 1H 2021). Net income: €491.3k (up €1.60m from 1H 2021). Profit margin: 1.6% (up from net loss in 1H 2021). Over the next year, revenue is forecast to grow 17%, compared to a 2.3% growth forecast for the Chemicals industry in Germany. Reported Earnings • Apr 29
Full year 2021 earnings released Full year 2021 results: Revenue: €47.6m (up 45% from FY 2020). Net loss: €234.6k (down 123% from profit in FY 2020). Over the next year, revenue is forecast to grow 19%, compared to a 10% growth forecast for the industry in Germany. Price Target Changed • Apr 27
Price target increased to €64.50 Up from €38.73, the current price target is provided by 1 analyst. New target price is 88% above last closing price of €34.35. Stock is down 17% over the past year. The company is forecast to post earnings per share of €0.16 for next year compared to €0.25 last year. Reported Earnings • Mar 21
Full year 2020 earnings released The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €42.2m (down 14% from FY 2019). Net income: €1.00m (up 16% from FY 2019). Profit margin: 2.4% (up from 1.8% in FY 2019). The increase in margin was driven by lower expenses. Is New 90 Day High Low • Feb 02
New 90-day high: €38.40 The company is up 146% from its price of €15.60 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €121 per share. Price Target Changed • Jan 27
Price target raised to €28.07 Up from €18.10, the current price target is an average from 3 analysts. The new target price is 20% below the current share price of €35.20. As of last close, the stock is up 135% over the past year. Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment deteriorated over the past week After last week's 18% share price decline to €29.20, the stock is trading at a trailing P/E ratio of 70.3x, down from the previous P/E ratio of 85.2x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 74%. Valuation Update With 7 Day Price Move • Dec 05
Market bids up stock over the past week After last week's 29% share price gain to €35.40, the stock is trading at a trailing P/E ratio of 79.4x, up from the previous P/E ratio of 61.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 115%. Valuation Update With 7 Day Price Move • Dec 03
Market bids up stock over the past week After last week's 23% share price gain to €35.60, the stock is trading at a trailing P/E ratio of 76.7x, up from the previous P/E ratio of 62.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 116%. Valuation Update With 7 Day Price Move • Nov 30
Market pulls back on stock over the past week After last week's 16% share price decline to €27.40, the stock is trading at a trailing P/E ratio of 64.4x, down from the previous P/E ratio of 76.6x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 70%. Valuation Update With 7 Day Price Move • Nov 19
Market bids up stock over the past week After last week's 18% share price gain to €18.70, the stock is trading at a trailing P/E ratio of 42.7x, up from the previous P/E ratio of 36.3x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 10%. Is New 90 Day High Low • Nov 12
New 90-day high: €16.60 The company is up 52% from its price of €10.90 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.81 per share. Valuation Update With 7 Day Price Move • Nov 02
Market bids up stock over the past week After last week's 29% share price gain to €16.50, the stock is trading at a trailing P/E ratio of 32x, up from the previous P/E ratio of 24.8x. This compares to an average P/E of 24x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 4.0%. Valuation Update With 7 Day Price Move • Oct 22
Market bids up stock over the past week After last week's 20% share price gain to €13.30, the stock is trading at a trailing P/E ratio of 30.4x, up from the previous P/E ratio of 25.3x. This compares to an average P/E of 31x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 19%. Valuation Update With 7 Day Price Move • Oct 19
Market bids up stock over the past week After last week's 16% share price gain to €13.40, the stock is trading at a trailing P/E ratio of 30.1x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 16%. Is New 90 Day High Low • Oct 19
New 90-day high: €13.40 The company is up 19% from its price of €11.30 on 21 July 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.88 per share.